Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Viela Bio (VIE) News Today

Viela Bio logo

VIE Latest News

RGNX-Aktie erreicht 52-Wochen-Tief bei 9,28 US-Dollar
Regenxbio Names Mitchell Chan CFO
2024 Fire Awards: Meet this year's Ablaze honorees
ArriVent BioPharma Files For IPO
Argenx stock price
Argenx's 28% Surge & Promising Product Propel Investor Confidence (VIE)
Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.
8-K: Horizon Therapeutics Public Ltd Co
SBI Holdings, Inc. (SBHGF) Q2 2023 Earnings Call Transcript
Viela Bio, Inc. News
CANbridge Appoints Industry Leader Edward Hu to the Board
Horizon: For Those Who Dare
Hansoh Pharmaceutical Group Co Ltd (3692)
Viela Bio Inc (VIE)
Get Viela Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIE and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VIE Media Mentions By Week

VIE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VIE
News Sentiment

0.00

1.05

Average
Medical
News Sentiment

VIE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VIE Articles
This Week

0

1

VIE Articles
Average Week

Get the Latest News and Ratings for VIE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Viela Bio and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:VIE) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners